Cargando…

Low glucose metabolism in hepatocellular carcinoma with GPC3 expression

AIM: To investigate the relationship between glucose metabolism and glypican-3 (GPC3) expression in hepatocellular carcinoma (HCC). METHODS: Immunohistochemical staining of pathological samples for GPC3 and glucose transporter 1 (GLUT1), and whole-body (18)F-FDG PET/CT for measuring tumour glucose u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, You-Cai, Yang, Chuan-Sheng, Zhou, Wen-Lan, Li, Hong-Sheng, Han, Yan-Jiang, Wang, Quan-Shi, Wu, Hu-Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2018
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787784/ https://www.ncbi.nlm.nih.gov/pubmed/29398870 http://dx.doi.org/10.3748/wjg.v24.i4.494

Ejemplares similares

Prognostic model of hepatocellular carcinoma based on cancer grade
por: Zhang, Guo-Xin, et al.
Publicado: (2023)

Radiomic analysis based on multi-phase magnetic resonance imaging to predict preoperatively microvascular invasion in hepatocellular carcinoma
por: Li, Yue-Ming, et al.
Publicado: (2022)

Risk factors for long-term prognosis of hepatocellular carcinoma patients after anatomic hepatectomy
por: Tian, Ya-Li, et al.
Publicado: (2020)

Postoperative outcomes and recurrence patterns of intermediate-stage hepatocellular carcinoma dictated by the sum of tumor size and number
por: Hu, Xin-Sheng, et al.
Publicado: (2022)

Effects of vitamin D supplementation on glucose and lipid metabolism in patients with type 2 diabetes mellitus and risk factors for insulin resistance
por: Sun, Li-Jie, et al.
Publicado: (2023)

Radiomics signature: A potential biomarker for β-arrestin1 phosphorylation prediction in hepatocellular carcinoma
por: Che, Feng, et al.
Publicado: (2022)

Identification of predictive factors for post-transarterial chemoembolization liver failure in hepatocellular carcinoma patients: A retrospective study
por: Yuan, Min, et al.
Publicado: (2022)

Percutaneous radiofrequency ablation is superior to hepatic resection in patients with small hepatocellular carcinoma
por: Zhang, Yan-Hua, et al.
Publicado: (2020)

Clinicopathological characteristics and surgical outcomes of sarcomatoid hepatocellular carcinoma
por: Wang, Jian-Ping, et al.
Publicado: (2020)

Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma?
por: Huang, Jia-Yan, et al.
Publicado: (2020)

Clinical implications of forkhead box M1, cyclooxygenase-2, and glucose-regulated protein 78 in breast invasive ductal carcinoma
por: Bai, Jie, et al.
Publicado: (2023)

GPC-3 in hepatocellular carcinoma: current perspectives
por: Wu, Yongle, et al.
Publicado: (2016)

Transarterial chemoembolization combined with radiofrequency ablation in the treatment of large hepatocellular carcinoma with stage C
por: Sun, Sha-Sha, et al.
Publicado: (2022)

Evaluating tumor-infiltrating lymphocytes in hepatocellular carcinoma using hematoxylin and eosin-stained tumor sections
por: Du, Min, et al.
Publicado: (2022)

Diagnostic value of gamma-glutamyltransferase/aspartate aminotransferase ratio, protein induced by vitamin K absence or antagonist II, and alpha-fetoprotein in hepatitis B virus-related hepatocellular carcinoma
por: Wang, Qiang, et al.
Publicado: (2019)

Accurate ultrasonography-based portal pressure assessment in patients with hepatocellular carcinoma
por: Zhang, Yu, et al.
Publicado: (2020)

Prognostic factors for disease-free survival in postoperative patients with hepatocellular carcinoma and construction of a nomogram model
por: Luo, Pan-Quan, et al.
Publicado: (2022)

Development and validation of a prediction model for microvascular invasion in hepatocellular carcinoma
por: Wang, Lin, et al.
Publicado: (2020)

Comprehensive radiomics nomogram for predicting survival of patients with combined hepatocellular carcinoma and cholangiocarcinoma
por: Tang, You-Yin, et al.
Publicado: (2021)

Simultaneous transarterial chemoembolization and radiofrequency ablation for large hepatocellular carcinoma
por: Duan, Feng, et al.
Publicado: (2020)

Efficacy and safety of computed tomography-guided microwave ablation with fine needle-assisted puncture positioning technique for hepatocellular carcinoma
por: Hao, Ming-Zhi, et al.
Publicado: (2022)

Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma
por: Deng, Peng-Zhan, et al.
Publicado: (2022)

Nomogram based on inflammation-related markers for predicting survival of patients undergoing hepatectomy for hepatocellular carcinoma
por: Pu, Tian, et al.
Publicado: (2021)

Prognostic factors and predictors of postoperative adjuvant transcatheter arterial chemoembolization benefit in patients with resected hepatocellular carcinoma
por: Chen, Ming-Yu, et al.
Publicado: (2020)

Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis
por: Li, Shao-Hua, et al.
Publicado: (2017)

Prostate-specific membrane antigen expression in hepatocellular carcinoma, cholangiocarcinoma, and liver cirrhosis
por: Chen, Li-Xing, et al.
Publicado: (2020)

Efficacy of tolvaptan for the patients with advanced hepatocellular carcinoma
por: Miyazaki, Masayuki, et al.
Publicado: (2017)

Hepatocellular carcinoma with tumor thrombus in bile duct: A proposal of new classification according to resectability of primary lesion
por: Zhou, Di, et al.
Publicado: (2020)

Early prediction of survival in hepatocellular carcinoma patients treated with transarterial chemoembolization plus sorafenib
por: Meng, Xiao-Chun, et al.
Publicado: (2018)

Cyclooxygenase-2 expression is associated with initiation of hepatocellular carcinoma, while prostaglandin receptor-1 expression predicts survival
por: Yang, Hao-Jie, et al.
Publicado: (2016)

Dual energy computed tomography for detection of metastatic lymph nodes in patients with hepatocellular carcinoma
por: Zeng, Yu-Rong, et al.
Publicado: (2019)

Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion
por: Ye, Jia-Zhou, et al.
Publicado: (2017)

Safety and efficacy of transjugular intrahepatic portosystemic shunt combined with palliative treatment in patients with hepatocellular carcinoma
por: Luo, Shi-Hua, et al.
Publicado: (2019)

End-stage liver disease score and future liver remnant volume predict post-hepatectomy liver failure in hepatocellular carcinoma
por: Kong, Fan-Hua, et al.
Publicado: (2019)

Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 is a diagnostic and prognostic biomarker for hepatocellular carcinoma
por: Cai, Yi, et al.
Publicado: (2020)

Transarterial embolization and low-dose continuous hepatic arterial infusion chemotherapy with oxaliplatin and raltitrexed for hepatocellular carcinoma with major portal vein tumor thrombus
por: Zhu, Lin-Zhong, et al.
Publicado: (2018)

Type 2 diabetes mellitus characteristics affect hepatocellular carcinoma development in chronic hepatitis B patients with cirrhosis
por: Li, Man-Yu, et al.
Publicado: (2023)

Development of a prognostic scoring system for resectable hepatocellular carcinoma
por: Sposito, Carlo, et al.
Publicado: (2016)

Features of extrahepatic metastasis after radiofrequency ablation for hepatocellular carcinoma
por: Yoon, Jae H, et al.
Publicado: (2020)

Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis
por: Elshaarawy, Omar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sticklu6pdob3t4m0sa7r307qp